Bizarre Patents
A kissing shield comprised of a thin, flexible membrane and a frame or holder.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7994357 | Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase The invention relates to a compound represented by the following formula (I): and pharmaceutically acceptable salts, stereoisomers, enantiomers, prodrugs and solvates thereof. The compounds are useful as an agent for enhanc... | 08/09/2011 |
| 7396923 | Method for the sulfonation of compounds comprising free hydroxyl (OH) groups or primary or secondary amines A method for sulfonating compounds having one or more free hydroxyl functional groups and/or one or more optionally substituted primary or secondary functional groups, including treating the compounds with a complex of SO3-DMF in the presence of an acid c... | 07/08/2008 |
| 7355021 | Single pot process for the preparation of diazonaphthoquinonesulfonyl ester The present invention provides a single pot process for the preparation of diazonaphthoquinonesulfonyl ester, a useful organic material for micro electronic and dye industry. This study pertains to the one pot preparation of diazonaphthoquinonesulfonyl esters using ... | 04/08/2008 |
| 7332621 | Process for preparing Tamsulosin The present invention relates to a process for preparing Tamsulosin, an anti-benign prostatic hyperplasia drug, which comprises converting o-ethoxyphenoxyethanol to a corresponding sulfonate, and reacting the sulfonate with (R)-(−)-5-(2-aminopropyl)-2-methoxybenze... | 02/19/2008 |
| 7244762 | Antitumoral d-homoestra-1,3,5 (10)-trien-3-yl 2-substituted sulfamates This invention relates to 2-substituted D-homo-estra-1,3,5(10)-trien-3-yl sulfamates of general formula I (I), in which R3 means a C1-C5-alkyl or C1-C5-alkyloxy group as well as their use for the production of a pharmaceutical agent for treating tumor diseases, whic... | 07/17/2007 |
| 7208477 | Treatments for benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases The subject invention provides methods and compositions for the treatment of benign tumors, cancers, neoplasias, and/or other inflammatory disorders or diseases. In the practice of the subject invention, and anti-convulsant agent, such as topiramate, is administered... | 04/24/2007 |
| 7196209 | Continuous process for the preparation of fructopyranose sulfamate derivatives The present invention is directed to a continuous process for the preparation of fructopyranose sulfamate derivatives of the general formula (I) wherein R1, R3, R | 03/27/2007 |
| 7157589 | One step process for the preparation of anticonvulsant derivatives The present invention is directed to a one-step process for the preparation of fructopyranose sulfamate derivatives of the general formula (I) wherein X, R1, R3, R | 01/02/2007 |
| 7119206 | Derivative of dihydro-dibenzo (a) anthracenes and their use as selective estrogen receptor modulators The present invention provides a compound of the formula (I) wherein R1 is —H, —OH, —O(C1–C4 alkyl), —OCOC6H5, —OCO(C1–C6 alkyl), or —OSO2(C2–C6... | 10/10/2006 |
| 7056890 | Combination therapy for effecting weight loss and treating obesity The present invention features a novel therapy for effecting weight loss which involves treating a subject with a sympathomimetic agent (e.g., phentermine or a phentermine-like drug) in combination with an anticonvulsant sulfamate derivative (e.g., topiramate) such ... | 06/06/2006 |
| 7034015 | Aminobenzoephenones The invention relates to a novel class of aminobenzophenones derivatives, to pharmaceutical preparations comprising said compounds, to dosage units of such preparations, to methods of treating patients comprising administering said compounds, and to the use of said ... | 04/25/2006 |
| 6992205 | Process for the production of sulfonic esters Sulfonic acid ester derivatives represented by the general formula (4) or (5) are produced by reacting an amino alcohol derivative represented by the general formula (1) or (2) with an organic sulfonyl halide represented by the general formula (3), in a mixed solven... | 01/31/2006 |
| 6888027 | Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors This invention pertains to certain active carbamic acid compounds which inhibit HDAC activity and which have the following formula: (I) A is an aryl group; Q1 is a covalent bond or an aryl leader group; J is a sulfonamide linkage selected from: —S(═O)... | 05/03/2005 |
| 6852755 | Nitrogen mustard compounds and prodrugs therefor This invention pertains to nitrogen mustard compounds (Formula (II)) and prodrugs therefor (Formula (I)), methods for their preparation, pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo,... | 02/08/2005 |
| 6756409 | Phenoxyphenyl alkanesulphonates The invention relates to novel phenoxyphenyl alkanesulphonates, processes for their preparation, their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment of states of pain and neurodegenerative disorders. | 06/29/2004 |
| 6730783 | Process for preparing aminoguanidines and alkoxyguanidines as protease inhibitors Aminoguanidine and alkoxyguanidine compounds, including compounds of the formula: wherein X is O or NR9 and R1-R4, R6-R9, R11, R12, Ra | 05/04/2004 |
| 6706765 | Aminoguanidines and alkoxyguanidines as protease inhibitors Aminoguanidine and alkoxyguanidine compounds, including compounds of the formula: wherein X is O or NR9 and R1-R4, R6-R9, R11, R12, Ra | 03/16/2004 |
| 6518310 | Aminoguanidines and alkoxyguanidines as protease inhibitors Aminoguanidine and alkoxyguanidine compounds, including compounds of the formula: ##STR1## wherein X is O or NR9 and R1 -R4, R6 -R9, R11, R12, Ra, Rb, R | 02/11/2003 |
| 6482860 | Pentafluorobenzenesulfonamides and analogs The invention provides methods and compositions relating to novel pentafluorophenylsulfonamide derivatives and analogs and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of dis... | 11/19/2002 |
| 6433000 | Compounds for the treatment of estrogen-dependent illnesses and methods of making and using the same Novel sulfatase inhibitor/estrogen receptor blocker compounds useful in the treatment of estrogen dependent illnesses are disclosed. The compounds generally comprise a sulfamate moiety and an aromatic, estrogen receptor blocker moiety. Methods for synthes... | 08/13/2002 |
| 6268520 | Tricyclic compounds Novel tricyclic compounds of formula I as defined in the specification, a process for their preparation and their use for the preparation of optically active or racemic colchicine and thiocolchicine derivatives.... | 07/31/2001 |
| 6248780 | Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same Novel sulfatase inhibitor/estrogen receptor blocker compounds useful in the treatment of estrogen dependent illnesses are disclosed. The compounds generally comprise a sulfamate moiety and an aromatic, estrogen receptor blocker moiety. Methods for synthes... | 06/19/2001 |
| 6187944 | Acrylonitrile compounds, process for their production and pesticides containing them Acrylonitrile compounds having pesticidal activity of formula (I) and salts thereof. ##STR1## wherein Q is ##STR2## Y is .dbd.C(R4)-- or .dbd.N--, R1 is alkyl, haloalkyl, etc., each of R2 and R3 is halogen,... | 02/13/2001 |
| 6169116 | Amino-tetralines, pharmaceutical compositions containing them and their pharmaceutical uses Compounds of formula I ##STR1## wherein R1, R2, R3, R4 and R5 are as defined in the description, are useful as pharmaceuticals.... | 01/02/2001 |
| 6111102 | Processes for preparing sulfonylureas Compounds of the formula I or salts thereof, in which X is oxygen, --O--NR2 -- or --SO2 --NR2 --, and Y is N or CH, R1 is (C1 -C6)alkyl, (C2 -C6)alkenyl or (C2 -... | 08/29/2000 |
| 6084131 | Process for the preparation of protected dihydroxypropyl trialkylammonium salts and derivatives thereof A process for the preparation of protected dihydroxypropyl trialkylammonium salts, particularly in chiral form is described. In particular, a process for the preparation of (2,2-dimethyl-1,3-dioxolan-4-ylmethyl)trialkylammonium salts, particularly in... | 07/04/2000 |
| 6075146 | Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceuticals The invention relates to intermediates and processes for producing benzothiophenes employing hydroxylamines.... | 06/13/2000 |
| 5952462 | Transition state analogs Antigens capable of eliciting antibodies which can catalyze chemical reactions, in particular, the cleavage or formation of a peptide linkage, comprising a hapten or a hapten and a suitable carrier molecule are disclosed. Haptens include, among others, si... | 09/14/1999 |
| 5912379 | Processes for preparing sulfonylureas Processes for preparing sulfonylureas Compounds of the formula I or salts thereof, ##STR1## in which X is oxygen, --O--NR2 -- or --SO2 --NR2 --, and Y is N or CH, R1 is (C1 -C6)alkyl, ... | 06/15/1999 |
| 5892088 | Sulfamate compound containing N-substituted carbamoyl group and method for preparing the same There are disclosed novel sulfamate compounds containing N-substituted carbomoyl group including their racemates and (R)- and (S)-optical isomers represented by Formulas I, II and III, pharmaceutically useful for the prophylaxis and treatment of the disor... | 04/06/1999 |
| 5869725 | Derivatives of aminosulfonic acids, utilization of the same in the synthesis of pseudopeptides and process for their preparation Derivatives of gamma-amino-alpha,beta-unsaturated sulfonic acids, a process for the preparation of the same and their utilization in the synthesis of pseudopeptides characterized by the presence of at least a sulfonamide type bond conjugated to a double b... | 02/09/1999 |
| 5811454 | 4-amino-fluorobenzamides and their use as cytotoxic prodrugs The invention provides a compound which is a 3-fluorobenzamide of the formula (A) ##STR1## wherein R-NH is the residue of an -amino acid R-NH2 or oligopeptide R-NH2, and M is a nitrogen mustard group of the formula #... | 09/22/1998 |
| 5804532 | Herbicidal 2-cyano-1,3-diones Herbicides derived from 2-cyano-1,3-diones have the formula: ##STR1## wherein R, R1, R2 R3, R4 and R5 are as defined in the description. The compounds are intended for use pre- and post-emergence... | 09/08/1998 |
| 5760006 | Anticonvulsant derivatives useful in treating psoriasis The use of compounds of the following formula I: ##STR1## for treating psoriasis is disclosed.... | 06/02/1998 |
| 5654461 | Sulfamate compound containing carbamoyl group 3-O-Carbamoyl-2-phenyl-1,3-propanediol sulfamate racemate, represented by the following structural formula I: ##STR1## and its (R)- and (S)-optical isomers, which are very effective for prophylaxis and the treatment of central nervous system disorder... | 08/05/1997 |
| 5550273 | Process for preparing fluorocarbon fluoroalkanesulfonates A process for preparing fluorocarbon fluoroalkanesulfonates comprises (a) forming a mixture comprising at least one fluoroalkanesulfonyl halide, e.g., perfluoromethanesulfonyl fluoride, at least one fluorocarbon-substituted carbinol, e.g., 1,1-dihydr... | 08/27/1996 |
| 5532410 | Process for manufacturing L(-)-carnitine from a waste product having opposite configuration L-(-)-carnitine is prepared from D-(+)-carnitinamide by (a) reacting D-(+)-carnitinamide in an acid medium with a straight or branched chain aliphatic alcohol thereby forming D-(+)-carnitine ester, (b) acylating the D-(+)-carnitine ester with an anhydride... | 07/02/1996 |
| 5491260 | Process for manufacturing L-(-)-carnitine from derivatives having a configuration opposite to that of L-(-)-carnitine A Process for Preparing L-(-)-carnitine is disclosed which comprises acylating D-(+)-carnitinenitrile or D-(+)-carnitineamide to their respective acyl derivatives which, via acid hydrolysis, yield D-(+)-carnitine which is converted to the lactone of L-(-)... | 02/13/1996 |
| 5488118 | Process for producing optically active erythro-3-amino-1,2-epoxy compound The present invention relates to a process for producing an optically active erythro-3-amino-1,2-epoxy compound represented by the following general formula (3): ##STR1## wherein R1 represents a hydrocarbon residue having 3 to 12 carbon atoms; a... | 01/30/1996 |
| 5468870 | Dyes and dye-donor elements for use in thermal dye sublimation transfer Dye-donor element for use according to thermal dye sublimation transfer comprising a support having thereon a dye layer containing a dye corresponding to the following formula ##STR1## wherein Z represents CN, COOR1 or CONR2 R | 11/21/1995 |
